What are the management options for a 16-year-old female with primary amenorrhea (absence of menstruation) or a female with secondary amenorrhea (loss of menstruation), considering potential underlying causes such as polycystic ovary syndrome (PCOS), hormonal imbalances, or lifestyle factors?

Management of Amenorrhea

Primary Amenorrhea Management

For a 16-year-old with primary amenorrhea, immediately perform Tanner staging, pregnancy testing, and obtain FSH, LH, prolactin, and TSH levels, followed by pelvic ultrasound to identify structural abnormalities or hormonal causes. 1

Initial Diagnostic Workup

• Pregnancy test must be performed first in all cases, regardless of sexual history 2
• Assess pubertal development using Tanner staging to determine if delayed puberty (no breast development by age 13) requires earlier intervention 1, 2
• Order first-line laboratory tests: FSH, LH, prolactin, TSH, and estradiol levels 1, 2
• Obtain pelvic ultrasound to assess uterine and ovarian anatomy, identifying outflow tract obstruction or Müllerian agenesis 1, 2

Interpretation and Management Based on Findings

If breast development is present but no uterus on ultrasound:

• Suspect Müllerian agenesis or androgen insensitivity syndrome 2
• Refer to gynecology for specialized evaluation and management 2

If elevated FSH (>40 mIU/mL) confirmed on repeat testing 4 weeks later:

• Diagnose primary ovarian insufficiency (POI) 2
• Initiate estrogen replacement therapy with cyclic progestogen to induce menstrual cycles and prevent bone loss 1
• Counsel that patients with POI can maintain unpredictable ovarian function and should not be presumed infertile 3, 4

If low FSH/LH with low estradiol:

• Diagnose hypogonadotropic hypogonadism 1
• Screen for eating disorders, excessive exercise, low BMI, and psychosocial stressors (functional hypothalamic amenorrhea) 2
• Initiate estrogen replacement therapy with cyclic progestogen 1

If elevated prolactin (>20 μg/L):

• Evaluate for pituitary adenoma with brain MRI 2
• Refer to endocrinology for prolactin-lowering medication management 1

Critical Timing Considerations

• 90% of peak bone mass is attained by age 18, making prompt treatment of hypoestrogenic states essential to prevent irreversible bone loss 1
• Refer to gynecology and/or endocrinology for any primary amenorrhea by age 16 with normal pubertal development, suspected outflow tract obstruction, absent uterus, or elevated FSH 2

---

Secondary Amenorrhea Management

For secondary amenorrhea, exclude pregnancy first, then obtain FSH, LH, prolactin, and TSH levels to differentiate between PCOS, functional hypothalamic amenorrhea, hyperprolactinemia, and primary ovarian insufficiency. 1, 5

Initial Diagnostic Approach

• Pregnancy test is the mandatory first step before any further evaluation 1, 5
• Obtain initial laboratory panel: FSH, LH, prolactin, and TSH 1
• Perform pelvic ultrasound to evaluate for polycystic ovarian morphology and uterine abnormalities 1
• Conduct progestin challenge test (progesterone 400 mg daily for 10 days) to determine estrogen status 1, 6

Red Flags Requiring Immediate Evaluation (Do Not Wait 6 Months)

• Galactorrhea suggesting hyperprolactinemia requires immediate workup regardless of amenorrhea duration 1, 5
• Headaches or visual changes suggesting pituitary pathology mandate urgent brain imaging 1
• Signs of eating disorder or significant weight loss (≥10% in 1 month or BMI <17.5) require immediate intervention 7, 1
• Symptoms of hyperandrogenism or thyroid dysfunction warrant earlier investigation 5

Management Based on Etiology

Functional Hypothalamic Amenorrhea (FHA) - 20-35% of cases:

• Address underlying stressors through counseling about stress management, adequate nutrition, and appropriate activity levels 1
• Calculate energy availability: patient must consume >30 kcal/kg fat-free mass/day 1
• Screen for eating disorders using validated tools, as adolescents commonly minimize or deny disordered eating 1
• Obtain DXA scan for bone mineral density if amenorrhea extends beyond 6 months 1
• Refer to sports dietitian for comprehensive nutrition assessment 7
• Refer to endocrinology if not experienced with FHA treatment 1
• Consider mid-luteal progesterone testing to confirm ovulation if cycles resume 1

Polycystic Ovary Syndrome (PCOS) - Most common cause:

• Diagnose with LH/FSH ratio >2, polycystic ovarian morphology on ultrasound, and signs of hyperandrogenism 2
• Obtain androgen profile for suspected PCOS 1
• Induce menstrual bleeding with cyclical progestogen (progesterone 200 mg daily at bedtime for 12 continuous days per 28-day cycle) 6, 8
• Screen for glucose intolerance, dyslipidemia, and metabolic syndrome 3, 4
• Prescribe oral contraceptives for patients desiring contraception or with acne/hirsutism 8

Hyperprolactinemia - 20% of cases:

• Measure serum prolactin at any time of day using age-specific and sex-specific reference ranges 1
• If elevated, obtain brain MRI to evaluate for pituitary adenoma 1
• Treat with prolactin-lowering drugs (dopamine agonists) 8
• Use cyclical progestogen or hormone replacement therapy for cycle disturbance 8
• Prescribe oral contraceptives if contraception is needed 8

Primary Ovarian Insufficiency (POI):

• Diagnose with elevated FSH (>40 mIU/mL) within menopausal range, confirmed on repeat testing 4 weeks later 1, 2
• Initiate hormonal replacement therapy to reduce risk of osteoporosis, cardiovascular disease, and urogenital atrophy 1
• Manage with multidisciplinary team including gynecologists, endocrinologists, dietitians, and psychologists 1
• Counsel that patients can maintain unpredictable ovarian function and should not be presumed infertile 3, 4

Bone Health Considerations

DXA scan indications (obtain if any of the following):

• Amenorrhea lasting >6 months 1
• BMI ≤17.5 kg/m² or <85% estimated weight 7
• Recent weight loss ≥10% in 1 month 7
• Menarche ≥16 years of age 7
• History of diagnosed eating disorder 7
• History of ≥1 stress fracture 7
• Prior Z-score between -1.0 and -2.0 7

Repeat DXA screening every 1-2 years to determine ongoing bone loss and evaluate treatment effectiveness 7

Common Pitfalls to Avoid

• Do not assume amenorrhea in athletes or stressed adolescents is benign - other pathology must be excluded through systematic evaluation 1
• Do not overlook eating disorders - adolescents frequently minimize or deny disordered eating behaviors 1
• Do not delay bone density assessment - prolonged hypoestrogenic states significantly increase osteoporosis risk, particularly critical in adolescents attaining peak bone mass 1
• Do not presume infertility in POI patients - they can maintain unpredictable ovarian function 3, 4

Special Consideration: Contraceptive-Induced Amenorrhea

• Amenorrhea occurring with hormonal contraceptive use does not require medical treatment and is not harmful, even when prolonged beyond 6 months 5